Compass Biomedical is developing novel products and technologies to translate stem cell based therapies to the marketplace. As a part of the Arteriocyte Family, Compass Biomedical has access to a strong pipeline of cutting edge research and development products as well as commercialization and clinical expertise, making Compass Biomedical an ideal choice for bridging the gap between basic research and clinical applications.
Compass Biomedical is developing novel products and technologies to translate stem cell based therapies to the marketplace. As a part of the Arteriocyte Family, Compass Biomedical has access to a strong pipeline of cutting edge research and development products as well as commercialization and clinical expertise, making Compass Biomedical an ideal choice for bridging the gap between basic research and clinical applications.
Product Description | Product Code | Quantity | ||
---|---|---|---|---|
Research Grade | ||||
PLUS™ Cell Culture Supplement –MSC Qualified (100 mL) | PLS1 | 1 per box | ||
PLUS™ Cell Culture Supplement –MSC Qualified (250 mL) | PLS2 | 1 per box | ||
PLUS™ Cell Culture Supplement –MSC Qualified (500 mL) | PLSA-0500 | 1 per box | ||
GMP Grade | ||||
GMP PLUS™ Cell Culture Supplement (100 mL) | PLS5 | 1 per box | ||
GMP PLUS™ Cell Culture Supplement (250 mL) | PLS6 | 1 per box | ||
GMP PLUS™ Cell Culture Supplement (500 mL) | PLSGB-0500 | 1 per box | ||
GMP PLUS™ Cell Culture Supplement (1000 mL) | PLSGB-1000 | 1 per box |